The Trump administration has unveiled a plan to update nutrient requirements in infant formula, marking the first comprehensive review of formula ingredients and nutrition in nearly three decades. The announcement, made Thursday by Health Secretary Robert F. Kennedy Jr., is part of his broader Make America Healthy Again (MAHA) initiative, which aims to address concerns over artificial dyes and other additives in the nation’s food supply.
The initial phase of the review proposes revised standards for iodine, manganese, vitamin A, and vitamin D in infant formula. Additionally, the Food and Drug Administration (FDA) is soliciting public feedback on including certain ingredients not currently mandated but frequently added for their nutritional benefits, such as arachidonic acid (ARA), docosahexaenoic acid (DHA), and L-carnitine. This nutrient evaluation is scheduled to proceed in three stages, culminating in a final rule encompassing all modifications.
The timing of the announcement coincides with the approaching midterm elections, where Democrats are poised to regain control of the House while the Senate outcome remains uncertain. Some advocates within the MAHA movement have expressed dissatisfaction with the Trump administration and indicated that “MAHA moms” could potentially abstain from voting, though the new measures on infant formula and the administration’s recent move to authorize the temporary sale of six unapproved peptides may appeal to some in the faction.
The Department of Health and Human Services stated the FDA will reassess 30 nutrients currently mandated in formulas. In connection with the review, the FDA released updated data on chemical contaminants in infant formula, describing the findings as “reassuring.” The agency reported that most tested formulas contained low or undetectable levels of chemical contaminants, aligning with earlier results released this year.
Nonetheless, concerns remain among some parents and experts who have called for stricter testing, particularly regarding heavy metals, sugar content, and seed oils used in formulas. Hundreds of public comments received during the review’s early stages reflect these issues.
Bill Marler, a food safety attorney, praised the initiative as substantive but urged further investigation into bacterial contaminants such as Clostridium botulinum, which causes infant botulism, a rare but serious illness linked to formula.
Industry representatives voiced support for the FDA’s efforts. The Infant Nutrition Council of America emphasized that infant formula is already “rigorously regulated” and meets necessary safety, quality, and nutritional standards.
From the academic community, Steven Abrams, a pediatrics professor at the University of Texas at Austin, described the proposals as professionally crafted. He noted that most changes are modest, with the potential increase in vitamin D possibly reducing the need for additional supplementation in formula-fed infants. However, Abrams acknowledged that more contentious topics, including the role of seed oils and sugars, were not addressed in this initial phase of the review.
Barry Popkin, a nutrition professor at the University of North Carolina, expressed cautious optimism about the draft but raised questions about the leadership within the agency overseeing the review amid concerns about other scientific issues during Kennedy’s tenure, such as recent vaccine policy changes. Popkin stressed the importance of precision in infant formula composition, warning that improper alterations could disrupt the delicate balance intended to replace breast milk.
The FDA’s phased review process indicates ongoing evaluation and potential future updates to infant formula standards as authorities balance nutritional adequacy with safety concerns raised by consumers and experts alike.